---
title: "阿司匹林的新角色：解锁T细胞抗转移潜能"
date: 2025-03-30T23:47:23Z
draft: ["false"]
tags: [
  "fetched",
  "今日病理"
]
categories: ["Acdemic"]
---
阿司匹林的新角色：解锁T细胞抗转移潜能 by 今日病理
------
<div><p><span leaf=""><span textstyle="">各位小伙伴们，今天为大家带来最近一项关于</span><span textstyle="">阿司匹林</span><span textstyle="">的研究，阿司匹林一直冠以神药的称号，今天又双叒叕“上热搜”啦～</span></span></p><p><span leaf=""><span textstyle="">该研究发表于2025年3月的</span><span textstyle="">nature</span><span textstyle="">杂志上，</span></span><span leaf=""><span textstyle="">在这篇文章中，研究者们</span><span textstyle="">探讨了阿司匹林在预防癌症转移方面的作用，发现其通过</span></span><span leaf=""><span textstyle="">限制</span></span><span leaf=""><span textstyle="">血小板衍生的血栓烷A2（TXA2）对</span></span><span leaf=""><span textstyle="">T细胞免疫的抑制</span></span><span leaf=""><span textstyle="">来</span></span><span leaf=""><span textstyle="">增强抗转移免疫</span></span><span leaf=""><span textstyle="">。</span></span></p><p><span leaf=""><span textstyle="">这篇论文的前言部分探讨了癌症转移的严重性及其对患者生存率的影响。转移是癌细胞从原发肿瘤扩散到远处器官的过程，全球约90%的癌症死亡与此相关。尽管在早期癌症的治疗上取得了一定进展，但许多患者在治疗后数月或数年内仍会出现转移复发。这是因为</span></span><span leaf=""><span textstyle="">微转移癌细胞</span></span><span leaf=""><span textstyle="">在初期缺乏已建立肿瘤的免疫抑制微环境，因此对免疫攻击相对脆弱。这一特性为开发利用免疫系统的抗转移疗法提供了机会，旨在防止早期癌症患者的复发。</span></span></p><p><span leaf=""><span textstyle="">研究者们发现，</span><span textstyle="">环氧合酶1（COX-1）抑制剂（如阿司匹林）</span><span textstyle="">能够增强对癌症转移的免疫反应，主要通过</span><span textstyle="">解除血小板衍生的血栓烯A2（TXA2）对T细胞的抑制作用</span><span textstyle="">。TXA2通过激活T细胞内的免疫抑制通路，抑制T细胞受体驱动的激酶信号传导、增殖和效应功能。通过对小鼠进行T细胞特异性条件性基因缺失实验，研究者发现缺失ARHGEF1基因的小鼠在转移部位的T细胞活化显著增加。这些发现为阿司匹林的抗转移机制提供了新的见解，并为更有效的抗转移免疫疗法的开发铺平了道路。</span></span></p><p><span leaf=""><span textstyle="">在这篇论文中，五个主要图（Figure 1 到 Figure 5）的研究方法和结果总结如下：</span></span></p><p><span leaf=""><span textstyle=""> </span></span><span leaf=""><span textstyle="">Figure 1: ARHGEF1 suppresses T cell immunity to cancer metastasis</span></span><span leaf=""><span textstyle="">    </span></span><page></page></p><p><span leaf=""><img data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/hicCwtwDKUYGmEvxtzf4hibdLgI8tkYickHcEIbvVNXsWTHCmYcjKFcnDZ1yQkkUupmicgyfNTCE9slZJVuDE3MnXQ/640?wx_fmt=png" data-ratio="1.615530303030303" data-w="528" data-backw="528" data-backh="853" src="https://mmbiz.qpic.cn/sz_mmbiz_png/hicCwtwDKUYGmEvxtzf4hibdLgI8tkYickHcEIbvVNXsWTHCmYcjKFcnDZ1yQkkUupmicgyfNTCE9slZJVuDE3MnXQ/640?wx_fmt=png"></span></p><p><span leaf=""><span textstyle="">研究方法：</span></span><span leaf=""><span textstyle="">    </span></span><page></page></p><p><span leaf=""><span textstyle="">• 研究了ARHGEF1在肿瘤转移中的作用，通过比较野生型（WT）和Arhgef1敲除（KO）小鼠的肿瘤转移情况。</span></span></p><p><span leaf=""><span textstyle="">• 使用B16黑色素瘤细胞和LL/2肺癌细胞进行静脉注射实验，评估肺和肝转移的数量。</span></span></p><p><span leaf=""><span textstyle="">• 在MMTV-PyMT转基因小鼠模型中，分析原发性乳腺肿瘤的自发转移。</span></span></p><p><span leaf=""><span textstyle="">结果：</span></span></p><p><span leaf=""><span textstyle="">• Arhgef1敲除小鼠在肺和肝中的转移频率显著降低。</span></span></p><p><span leaf=""><span textstyle="">• Arhgef1缺失对多种转移位点的肿瘤发展有抑制作用。</span></span></p><p><span leaf=""><span textstyle="">• 骨髓移植实验表明，造血细胞中ARHGEF1的缺失足以减少肿瘤转移。</span></span></p><p><span leaf=""><span textstyle="">• 转移性肺组织中免疫激活和细胞毒性功能相关基因的表达增加。          </span></span><p><span leaf=""><span textstyle=""> </span></span></p></p><p><span leaf=""><span textstyle="">Figure 2: Loss of ARHGEF1 promotes CD8+ T cells with enhanced cytokine polyfunctionality</span></span><span leaf=""><span textstyle="">    </span></span><page></page></p><p><span leaf=""><img data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/hicCwtwDKUYGmEvxtzf4hibdLgI8tkYickHicM2EkkJxgtupQ2diavH339o931toZCvFiaNsNgy7yKQibibW5vRuryGdmA/640?wx_fmt=png" data-ratio="1.273394495412844" data-w="545" data-backw="545" data-backh="694" src="https://mmbiz.qpic.cn/sz_mmbiz_png/hicCwtwDKUYGmEvxtzf4hibdLgI8tkYickHicM2EkkJxgtupQ2diavH339o931toZCvFiaNsNgy7yKQibibW5vRuryGdmA/640?wx_fmt=png"></span></p><p><span leaf=""><span textstyle="">研究方法：</span></span></p><p><span leaf=""><span textstyle="">• 通过流式细胞术分析肺浸润T细胞的细胞因子多功能性。</span></span></p><p><span leaf=""><span textstyle="">• 比较野生型和Arhgef1敲除小鼠在肿瘤转移模型中的T细胞功能。</span></span></p><p><span leaf=""><span textstyle="">• 分析肿瘤抗原特异性CD8+ T细胞的细胞因子表达和耗竭标志物。</span></span></p><p><span leaf=""><span textstyle="">结果：</span></span><span leaf=""><span textstyle="">    </span></span><page></page></p><p><span leaf=""><span textstyle="">• Arhgef1敲除小鼠的CD8+ T细胞表现出更高的细胞因子多功能性。</span></span></p><p><span leaf=""><span textstyle="">• 肿瘤抗原特异性CD8+ T细胞中耗竭标志物PD-1和TOX的表达减少。</span></span></p><p><span leaf=""><span textstyle="">• Arhgef1缺失增强了记忆前体效应细胞（MPECs）的比例。        </span></span><p><span leaf=""><span textstyle=""> </span></span></p></p><p><span leaf=""><span textstyle=""> </span></span><span leaf=""><span textstyle="">Figure 3: TXA2 suppresses T cells via ARHGEF1</span></span></p><p><span leaf=""><img data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/hicCwtwDKUYGmEvxtzf4hibdLgI8tkYickHFs6CKrgibqc9N2Qic4n5XZh7vV5Dzqd1PR2kfCfob7ICYs9tyWMvEHog/640?wx_fmt=png" data-ratio="1.1635687732342008" data-w="538" data-backw="538" data-backh="626" src="https://mmbiz.qpic.cn/sz_mmbiz_png/hicCwtwDKUYGmEvxtzf4hibdLgI8tkYickHFs6CKrgibqc9N2Qic4n5XZh7vV5Dzqd1PR2kfCfob7ICYs9tyWMvEHog/640?wx_fmt=png"></span></p><p><span leaf=""><span textstyle="">研究方法：</span></span></p><p><span leaf=""><span textstyle="">• 通过体外实验筛选Gα12/13偶联的GPCR，确定其是否通过ARHGEF1抑制T细胞。</span></span></p><p><span leaf=""><span textstyle="">• 使用U46619（TXA2类似物）刺激T细胞，评估其对T细胞激活和增殖的影响。</span></span><span leaf=""><span textstyle="">    </span></span></p><p><span leaf=""><span textstyle="">结果：</span></span></p><p><span leaf=""><span textstyle="">• TXA2类似物在ARHGEF1依赖的方式下抑制T细胞的激活和增殖。</span></span></p><p><span leaf=""><span textstyle="">• TXA2类似物处理后，T细胞的细胞因子多功能性降低。</span></span></p><p><span leaf=""><span textstyle="">• TXA2受体（TP）的信号传导在抑制T细胞中起关键作用。</span></span></p><p><span leaf=""><span textstyle="">Figure 4: TXA2 limits TCR-driven kinase signaling</span></span></p><p><span leaf=""><img data-src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/hicCwtwDKUYGmEvxtzf4hibdLgI8tkYickH4C1dfqeCpXgiarFibicEzlpTysQibhzlcuAOGRa0zRa99IsiaibaoyY90aFQ/640?wx_fmt=jpeg" data-ratio="1.1850533807829182" data-w="562" data-croporisrc="http://mmbiz.qpic.cn/sz_mmbiz_png/hicCwtwDKUYGmEvxtzf4hibdLgI8tkYickHJMXVxDtxv7lRpwb8UI9kWBkDSt6Qia4LEcNwd7WXC0FO9AkwZt2p79g/0?wx_fmt=png" data-cropx2="562" data-cropy1="99.17647058823529" data-cropy2="765.2145328719722" data-backw="562" data-backh="766" src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/hicCwtwDKUYGmEvxtzf4hibdLgI8tkYickH4C1dfqeCpXgiarFibicEzlpTysQibhzlcuAOGRa0zRa99IsiaibaoyY90aFQ/640?wx_fmt=jpeg"></span></p><p><span leaf=""><span textstyle="">研究方法：</span></span></p><p><span leaf=""><span textstyle="">• 通过RNA-seq分析，研究TXA2类似物处理对T细胞转录组的影响。</span></span></p><p><span leaf=""><span textstyle="">• 使用磷酸化抗体检测TCR驱动的激酶信号通路的变化。     </span></span><p><span leaf=""><span textstyle=""> </span></span></p><span leaf=""><span textstyle="">    </span></span><page></page></p><p><span leaf=""><span textstyle="">结果：</span></span></p><p><span leaf=""><span textstyle="">• TXA2类似物处理抑制了与T细胞激活和效应分化相关的基因表达。</span></span></p><p><span leaf=""><span textstyle="">• TXA2通过ARHGEF1激活RHOA，抑制TCR驱动的PI3K和MAPK信号通路。</span></span></p><p><span leaf=""><span textstyle="">• TXA2信号传导导致PTEN向细胞皮层募集，进一步抑制AKT磷酸化。</span></span><p><span leaf=""><span textstyle=""> </span></span></p></p><p><p><span leaf=""><span textstyle="">Figure 5: Aspirin promotes anti-metastatic immunity by releasing T cells from ARHGEF1-dependent suppression by TXA2</span></span></p></p><p><span leaf=""><img data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/hicCwtwDKUYGmEvxtzf4hibdLgI8tkYickHGaiaLYy26Loq8GdcMg2Qb7cJBGGXsdTwibfvjP4Dia4hMmDY8ibNujECBQ/640?wx_fmt=png" data-ratio="1.2523191094619666" data-w="539" src="https://mmbiz.qpic.cn/sz_mmbiz_png/hicCwtwDKUYGmEvxtzf4hibdLgI8tkYickHGaiaLYy26Loq8GdcMg2Qb7cJBGGXsdTwibfvjP4Dia4hMmDY8ibNujECBQ/640?wx_fmt=png"></span><span leaf=""><span textstyle="">    </span></span><page></page></p><p><span leaf=""><span textstyle="">研究方法：</span></span></p><p><span leaf=""><span textstyle="">• 通过体内实验，评估阿司匹林对肿瘤转移的影响。</span></span></p><p><span leaf=""><span textstyle="">• 使用TXA2类似物和阿司匹林联合治疗，评估其对肿瘤转移的抑制效果。</span></span></p><p><span leaf=""><span textstyle="">结果：</span></span></p><p><span leaf=""><span textstyle="">• 阿司匹林治疗减少了肺转移的频率，并增加了T细胞的信号传导能力。</span></span></p><p><span leaf=""><span textstyle="">• 阿司匹林的抗转移活性依赖于T细胞中ARHGEF1的表达。</span></span></p><p><span leaf=""><span textstyle="">• 阿司匹林通过抑制血小板COX-1依赖的TXA2产生来释放T细胞。</span></span></p><p><span leaf=""><span textstyle="">• 阿司匹林的抗转移活性可以通过补充TXA2类似物来逆转。</span></span><span leaf=""><span textstyle="">    </span></span><page></page></p><p><mp-style-type data-value="3"></mp-style-type></p></div>  
<hr>
<a href="https://mp.weixin.qq.com/s/2Sv_8_0lnthq9BjxcC1Q0w",target="_blank" rel="noopener noreferrer">原文链接</a>
